drugset / Trial / NCT00375960

A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain

NCT00375960 ↗

RandomizedCrossoverDouble-blindTreatment

Summary

The objective of this study is to investigate the safety and efficacy of an investigational drug, V3381, for the treatment of diabetic peripheral neuropathic (DPN) pain (pain in one's feet and legs, or even in one's hands and arms, sometimes experienced by people with diabetes). An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA) and/or Health Canada.

Timeline

Start
2006-06
Primary completion
—
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Indantadol Unknown 200 mg Oral
Subject Indantadol Unknown 400 mg Oral

Indications